WallStreetZenWallStreetZen

NASDAQ: PRQR
Proqr Therapeutics Nv Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Proqr Therapeutics Nv earnings were -$34.3M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest PRQR earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$11.0M, up 13% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PRQR reported annual earnings of -$28.9M, with -7.4% growth.

PRQR earnings history

Current Revenue
$21.3M
Current Earnings
-$32.8M
Current Profit Margin
-153.8%

PRQR Return on Equity

Current Company
-53.6%
Current Industry
-60.2%
Current Market
31.4%
PRQR's Return on Equity (-53.6%)... subscribe to Premium to read more.
High Return on Equity Performance

PRQR undefined

Current Company
-22.2%
Current Industry
-2.5%
PRQR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when PRQR announces earnings.

PRQR undefined

Current Company
-24.81%
Current Industry
5.8%
PRQR has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PRQR vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
PRQR-$30.14M-$34.30MN/A-$0.36
CRDF-$48.32M-$48.88MN/A-$0.92
MDWD-$18.84M-$21.22MN/A-$2.04
DRTS-$26.34M-$31.75MN/A-$0.45
IMABN/A-$7.58MN/A-$0.12
View Top Biotech Stocks

Proqr Therapeutics Nv Earnings Reports & History FAQ

What were Proqr Therapeutics Nv's earnings last quarter?

On PRQR's earnings call on Invalid Date, Proqr Therapeutics Nv (NASDAQ: PRQR) reported Q1 2025 earnings per share (EPS) of -$0.11, up 11.22% year over year. Total PRQR earnings for the quarter were -$10.96 million. In the same quarter last year, Proqr Therapeutics Nv's earnings per share (EPS) was -$0.10.

If you're new to stock investing, here's how to buy Proqr Therapeutics Nv stock.

Is Proqr Therapeutics Nv profitable or losing money?

As of the last Proqr Therapeutics Nv earnings report, Proqr Therapeutics Nv is currently losing money. Proqr Therapeutics Nv's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$32.81 million, a 12.44% increase year over year.

What was PRQR's earnings growth in the past year?

As of Proqr Therapeutics Nv's earnings date in Invalid Date, Proqr Therapeutics Nv's earnings has grown year over year. PRQR earnings in the past year totalled -$34.30 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.